Orchid Pharma share news, announcements and annual reports
NSE: ORCHPHARMABSE: 524372Pharmaceuticals & BiotechnologySmall Cap
Orchid Pharma Limited · Formerly Orchid Chemicals & Pharmaceuticals · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 1993 on BSE, Jul 2010 on NSE
Last close ₹836.45down ₹56.95 (6.37%)BSE ₹833.05
Share price at the NSE close on 30 Oct 2026. Previous close ₹893.40.
30 Oct: open ₹893.45, high ₹893.45, low ₹830.00
52-week range of traded prices to 30 Oct 2026
₹480.00Low, 30 Mar 2026₹1,143.50High, 22 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹5,009 Cr919th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 0.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.19
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 88,12456.8% delivered
Orchid Pharma dividends
7 filed, newest first.
May 2012
14 May · Dividend
Board of Directors of the Company at its meeting held on May 14, 2012 has recommended a dividend of Rs. 3/- per share on the equity share of Rs.10/- each. Further, the dividend on Equity shares, will be paid subject to the approval of shareholders in the ensuing Annual General Meeting, and the same will be paid / dispatched during 2nd week of August 2012.
May 2011
18 May · Dividend
Dividend on Equity shares, if approved by the Members at the ensuing Annual General Meeting, will be paid / dispatched between August 16, 2011 and August 18, 2011.18 May · Dividend
Board of Directors of the Company at its meeting held on May 18, 2011 has recommended a dividend of Rs.3/- per share on the equity share of Rs.10/- each.
May 2010
27 May · Dividend
Board of Directors of the Company, at their meeting held on May 27, 2010 have recommended a dividend of Re.10/- per share on the equity share of Rs.10/- each.
Jun 2009
29 Jun · Dividend
Board of Directors of the Company at its meeting held on June 29, 2009 has recommended a dividend of Re. 1/- per share on the equity share of Rs.10/- each.
May 2008
29 May · Dividend
Board of Directors of the Company at its meeting held on May 29, 2008 has recommended a dividend of 30% (Rs.3/- per share) on the equity share of Rs.10/- each.
May 2007
3 May · Dividend
Board of Directors of the Company at its meeting held on May 03, 2007 have recommended a dividend of 30% (Rs.3/- per share) on the equity share of Rs.10/- each.